Groups | Chi-square or T test | |||||
---|---|---|---|---|---|---|
Naïve | Relapser | |||||
N | % | N | % | X2 or T | P value | |
Gender | ||||||
Male | 13 | 65.00 | 9 | 45.00 | 1.616 | 0.204 |
Female | 7 | 35.00 | 11 | 55.00 | ||
Age | ||||||
Range | 21–63 | 34–48 | 1.267 | 0.213 | ||
Mean ± SD | 43.550 ± 11.038 | 40.200 ± 4.238 | ||||
PCR (IU/ml) | ||||||
Range | 335,040–3,132,444 | 10,100–1,003,700 | 5.425 | < 0.001* | ||
Mean ± SD | 1,532,926.05 ± 963,954.961 | 310,582.200 ± 293,212.793 | ||||
Total leucocytic count (X 10^9 cells/L) | ||||||
Range | 4.3–10 | 4.5–10 | 0.069 | 0.945 | ||
Mean ± SD | 7.050 ± 1.558 | 7.015 ± 1.629 | ||||
Hemoglobin (g/dl) | ||||||
Range | 11–17.9 | 12.1–16 | 1.131 | 0.265 | ||
Mean ± SD | 14.500 ± 1.540 | 14.020 ± 1.108 | ||||
Platelet (X 10^9cells/L) | ||||||
Range | 109–321 | 87–230 | 2.137 | 0.039* | ||
Mean ± SD | 166.350 ± 53.524 | 135.250 ± 37.022 | ||||
Prothrombin Time | ||||||
Range | 11.5–14 | 11–13 | 3.116 | 0.003* | ||
Mean ± SD | 12.590 ± 0.713 | 11.943 ± 0.595 | ||||
AST (U/L) | ||||||
Range | 16–89 | 23–88 | − 0.117 | 0.907 | ||
Mean ± SD | 46.550 ± 17.707 | 47.200 ± 17.374 | ||||
ALT (U/L) | ||||||
Range | 22–62 | 25–77 | − 1.655 | 0.106 | ||
Mean ± SD | 38.300 ± 12.520 | 45.600 ± 15.250 | ||||
Total bilirubin (mg/dl) | ||||||
Range | 0.5–1.4 | 0.4–1.7 | − 0.287 | 0.776 | ||
Mean ± SD | 0.930 ± 0.236 | 0.956 ± 0.329 | ||||
Albumin (g/dl) | ||||||
Range | 3.7–4.5 | 3.6–4.4 | 0.286 | 0.777 | ||
Mean ± SD | 4.030 ± 0.232 | 4.010 ± 0.210 | ||||
Creatinine mg/dl | ||||||
Range | 0.34–1.36 | 0.57–1.2 | 1.07 | 0.124 | ||
Mean ± SD | 0.98 ± 0.25 | 0.92 ± 0.19 |